CYBO aids in the accurate diagnosis of various diseases, cellular medicine, and bioproduction.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Tokyo
State: Tokyo
Zip:
Country: Japan
CYBO applies AI to give cells an increase in intelligence. Their cell-measuring technology is made to identify and comprehend cells. By combining hardware like high-speed imaging with software like artificial intelligence and image processing, they can perform cell analysis. They provide a framework that can be used for the manufacture of medications and food items in addition to the diagnosis and treatment of illnesses. Its cell measurement technology is intended to better understand and distinguish cells. This is the foundational technology that they are proud to offer to the world. Furthermore, they have advanced cell analysis by combining software technologies such as AI and image processing with hardware technologies such as high-speed imaging.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2020 | Seed Round | 1 | $568.4k |
Incubate Fund Incubate Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|